Tissue engineering for tendon repair.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17062654.
- Also identified by PMC identifier 2465448.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tissue engineering aims to induce tissue self-regeneration in vivo or to produce a functional tissue replacement in vitro to be then implanted in the body. To produce a viable and functional tendon, a uniaxially orientated collagen type I matrix has to be generated. Biochemical and physical factors can potentially alter both the production and the organisation of this matrix, and their combination in a dose- and time-dependent manner is probably the key to in vitro engineered tendons. This review discusses the role of these different factors affecting tenocyte growth in a three-dimensional environment in vivo and in vitro, and underlines the future challenge of tendon tissue engineering.
Medical subject headings
- Biocompatible Materials
- Plastic Surgery Procedures
- Tendon Injuries
- Tendons
- Tissue Engineering